| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-07 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-05 |